Abstract
Pepsin-digested soy protein hydrolysate (SPH) has been reported to be responsible for many of the physiological benefits associated with soy protein consumption. In the present study, we investigated the effects of SPH with angiotensin-converting enzyme (ACE) inhibitory potential on blood pressure and renal injuries in rats with Nω-nitro- L -arginine methyl ester hydrochloride (L-NAME)–induced hypertension. Rats were fed a diet containing L-NAME (50 mg/kg body weight) with or without SPH (at 1%, 3%, or 5%) for 6 weeks. We found that ingestion of SPH ameliorated the development of hypertension during the 6-week experimental period. SPH was also found to ameliorate renal function by decreasing urinary protein excretion and elevating the creatinine clearance rate. The levels of kidney ACE activity, malonaldehyde, tumor necrosis factor-α and plasminogen activator inhibitor-1, and the expression of CYP4A decreased in the 5% SPH group. Consumption of 5% SPH also ameliorated renal damage according to the histopathological analysis. These findings suggest that SPH might ameliorate the elevation of blood pressure and show renoprotective effects in nitric oxide (NO)–deficient rats, and one possible mechanism might be mediation via its ACE inhibitory activity.
Similar content being viewed by others
Article PDF
References
Chobanian AV, Bakris GL, Black HR, et al: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252.
Codreanu I, Perico N, Remuzzi G : Dual blockade of the renin-angiotensin system: the ultimate treatment for renal protection? J Am Soc Nephrol 2005; 16 ( Suppl 1): S34–S38.
Sharifi AM, Akbarloo N, Darabi R : Investigation of local ACE activity and structural alterations during development of L-NAME-induced hypertension. Pharmacol Res 2005; 52: 438–444.
Pereira LM, Bezerra DG, Machado DL, Mandarim-de-Lacerda CA : Enalapril attenuates cardiorenal damage in nitricoxide- deficient spontaneously hypertensive rats. Clin Sci (Lond) 2004; 106: 337–343.
Katoh M, Egashira K, Mitsui T, Takeshita A, Narita H : Differential effects of imidapril and candesartan cilexetil on plasminogen activator inhibitor-1 expression induced by prolonged inhibition of nitric oxide synthesis in rat hearts. J Cardiovasc Pharmacol 2000; 35: 932–936.
Ying L, Flamant M, Vandermeersch S, et al: Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide- deficient rats. Hypertension 2003; 42: 937–944.
Mallikarjun Gouda KG, Gowda LR, Rao AG, Prakash V : Angiotensin I–converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max). J Agric Food Chem 2006; 54: 4568–4573.
Matsui T, Li CH, Tanaka T, Maki T, Osajima Y, Matsumoto K : Depressor effect of wheat germ hydrolysate and its novel angiotensin I–converting enzyme inhibitory peptide, Ile-Val-Tyr, and the metabolism in rat and human plasma. Biol Pharm Bull 2000; 23: 427–431.
Chen ST, Peng SJ, Chen JR : Effects of dietary protein on renal function and lipid metabolism in five-sixths nephrectomized rats. Br J Nutr 2003; 89: 491–497.
Yang HY, Yang SC, Chen JR, Tzeng YH, Han BC : Soyabean protein hydrolysate prevents the development of hypertension in spontaneously hypertensive rats. Br J Nutr 2004; 92: 507–512.
Marcantoni C, Jafar TH, Oldrizzi L, Levey AS, Maschio G : The role of systemic hypertension in the progression of nondiabetic renal disease. Kidney Int Suppl 2000; 75: S44–S48.
Graciano ML, Cavaglieri R de C, Delle H, et al: Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 2004; 15: 1805–1815.
Hernandez-Ledesma B, Martin-Alvarez PJ, Pueyo E : Assessment of the spectrophotometric method for determination of angiotensin-converting-enzyme activity: influence of the inhibition type. J Agric Food Chem 2003; 51: 4175–4179.
Bradford MM : A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254.
Miranda KM, Espey MG, Wink DA : A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001; 5: 62–71.
Aebi H : Catalase in vitro. Methods Enzymol 1984; 105: 121–126.
Griesmacher A, Kindhauser M, Andert SE, et al: Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 1995; 98: 469–475.
Ito O, Omata K, Ito S, Hoagland KM, Roman RJ : Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid. Am J Physiol Regul Integr Comp Physiol 2001; 280: R822–R830.
Chen JR, Okada T, Muramoto K, Suetsuna K, Yang SC : Identification of angiotensin I–converting enzyme inhibitory peptides derived from the peptic digest of soybean protein. J Food Biochem 2003; 26: 543–554.
Chen ST, Yang HY, Huang HY, Peng SJ, Chen JR : Effects of various soya protein hydrolysates on lipid profile, blood pressure and renal function in five-sixths nephrectomized rats. Br J Nutr 2006; 96: 435–441.
Lo WM, Li-Chan EC : Angiotensin I converting enzyme inhibitory peptides from in vitro pepsin-pancreatin digestion of soy protein. J Agric Food Chem 2005; 53: 3369–3376.
Khattab MM, Mostafa A, Al-Shabanah O : Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide–deficient hypertensive rat. Kidney Blood Press Res 2005; 28: 243–250.
MacLaughlin M, Monserrat AJ, Muller A, Matoso M, Amorena C : Role of kinins in the renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure. Kidney Blood Press Res 1998; 21: 329–334.
Zhou MS, Schulman IH, Raij L : Nitric oxide, angiotensin II, and hypertension. Semin Nephrol 2004; 24: 366–378.
Trujillo J, Ramirez V, Perez J, et al: Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation. Am J Physiol Renal Physiol 2005; 288: F108–F116.
Kitamoto S, Egashira K, Kataoka C, et al: Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. J Hypertens 2000; 18: 1795–1800.
Gonzalez W, Fontaine V, Pueyo ME, et al: Molecular plasticity of vascular wall during N(G)-nitro-L-arginine methyl ester–induced hypertension: modulation of proinflammatory signals. Hypertension 2000; 36: 103–109.
Mahn K, Borras C, Knock GA, et al: Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J 2005; 19: 1755–1757.
Pedraza-Chaverri J, Barrera D, Hernandez-Pando R, et al: Soy protein diet ameliorates renal nitrotyrosine formation and chronic nephropathy induced by puromycin aminonucleoside. Life Sci 2004; 74: 987–999.
Ruiz-Ortega M, Esteban V, Ruperez M, et al: Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr Opin Nephrol Hypertens 2006; 15: 159–166.
Chen R, Iwai M, Wu L, et al: Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury. Hypertension 2003; 42: 542–547.
Okada H, Watanabe Y, Kikuta T, et al: Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade. J Am Soc Nephrol 2004; 15: 2404–2413.
Oyekan AO, Youseff T, Fulton D, Quilley J, McGiff JC : Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are diffrentially modified by nitric oxide and sodium chloride. J Clin Invest 1999; 104: 1131–1137.
Wang JS, Singh H, Zhang F, et al: Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus. Circ Res 2006; 98: 962–969.
Alonso-Galicia M, Maier KG, Greene AS, Cowley A W Jr, Roman RJ : Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol 2002; 283: R60–R68.
Yaghini FA, Zhang C, Parmentier JH, et al: Contribution of arachidonic acid metabolites derived via cytochrome P4504A to angiotensin II–induced neointimal growth. Hypertension 2005; 45: 1182–1187.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, HY., Chen, JR. Renoprotective Effects of Soy Protein Hydrolysates in Nω-Nitro-L-Arginine Methyl Ester Hydrochloride—Induced Hypertensive Rats. Hypertens Res 31, 1477–1483 (2008). https://doi.org/10.1291/hypres.31.1477
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.31.1477
